INREBIC

What this means for you

Registered since 05 Apr 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 05 Apr 2026).

Record

Serial number

86690908

Registration number

4931750

Mark type

Stylized text

Filed

13 Jul 2015

Published for opposition

19 Jan 2016

Registered

05 Apr 2016

Next maintenance due

05 Apr 2026

Attorney of record

Marilyn F. Kelly

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, [ autoinflammatory disease, autoimmune disease, ] blood disease, cancer, [ arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; ] pharmaceutical preparations, namely, cytokine inhibitory drugs; [ pharmaceutical preparations that modulate the immune system ]

Owner

• IMPACT BIOMEDICINES, INC., SUMMIT, NJ, US
• Celgene Corporation, Summit, NJ, US
• Celgene Corporation, Summit, NJ, US
• Celgene Corporation, Summit, NJ, US

Prosecution history

• 30 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
• 30 Mar 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
• 30 Mar 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
• 29 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 16 Jan 2026 — TEAS SECTION 8 & 9 RECEIVED
• 05 Apr 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
• 07 Sept 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
• 07 Sept 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
• 07 Sept 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 15 Mar 2022 — TEAS SECTION 8 & 15 RECEIVED
• 05 Apr 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
• 06 Feb 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
• 05 Apr 2016 — REGISTERED-PRINCIPAL REGISTER
• 19 Jan 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 19 Jan 2016 — PUBLISHED FOR OPPOSITION